First-line axitinib versus sorafenib in Asian patients with...

  • Main
  • 2018 / 07
  • First-line axitinib versus sorafenib in Asian patients with...

First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data

Sheng, Xinan, Bi, Feng, Ren, Xiubao, Cheng, Ying, Wang, Jinwan, Rosbrook, Brad, Jiang, Ming, Guo, Jun
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2018-0442
Date:
July, 2018
File:
PDF, 1.47 MB
english, 2018
Conversion to is in progress
Conversion to is failed